Co víme o incidenci chronické lymfocytární leukemie (CLL), a kde a jak jsou nemocní s CLL léčeni?

• Title in English: What we know about the incidence of CLL and where and how they treated patients with CLL?
• Authors: DOUBEK Michael; PANOVSKÁ Anna; JANČA J.; JUDÁSKOVÁ L.; MELUZÍNOVÁ I.; HEJLOVÁ N.; BARTOŠOVÁ R.; SIMONIDES J.; JAJTNER P.; GAJA A.; INGROVÁ L.; MAŠKOVÁ M.; VESELÁ H.; PEPRLA J.; PRAŽÁKOVÁ L.; ZVAROVÁ M.; KRAHULCOVÁ E.; BULIKOVÁ A.; ŠEVČÍKOVÁ I.; DOSTÁLOVÁ V.; BRYCHTOVÁ Yvona; MAYER Jiří
• Year of publication: 2010
• Type: Article in Periodical
• Magazine / Source: Transfuze a Hematologie dnes
• MU Faculty or unit: Faculty of Medicine
• Field: Oncology and hematology
• Keywords: chronic lymphocytic leukemia; epidemiology; treatment
• Description: Currently, pathogenesis, modern prognostic factors, or modern therapy in chronic lymphocytic leukemia(CLL) are frequently discussed, however, up-to-date data concerning the incidence and the management of CLL in real life are still missing. The aim of our study was to find out the actual epidemiological situation of CLL, and the diagnostic and therapeutic preferences of hematologists in the preselect area- the South Moravian Region.

Related projects

• Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies